🇺🇸 FDA
Patent

US 11992530

Therapeutic uses for sodium thiosulfate and formulations

granted A61KA61K33/04A61K33/243

Quick answer

US patent 11992530 (Therapeutic uses for sodium thiosulfate and formulations) held by Fennec Pharn ceuticals Inc. expires Mon May 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Fennec Pharn ceuticals Inc.
Grant date
Tue May 28 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K33/04, A61K33/243, A61K47/02, A61K47/18